Disulfide isomerization switches tissue factor from coagulation to cell signaling

被引:278
作者
Ahamed, Jasimuddin
Versteeg, Henri H.
Kerver, Marjolein
Chen, Vivien M.
Mueller, Barbara M.
Hogg, Philip J.
Ruf, Wolfram
机构
[1] Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA
[2] La Jolla Inst Mol Med, San Diego, CA 92121 USA
[3] Univ New S Wales, Ctr Vasc Res, Sydney, NSW 2052, Australia
关键词
allosteric disulfide; protein disulfide; isomerase; S-nitrosylation; G protein-coupled receptor;
D O I
10.1073/pnas.0606411103
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Cell-surface tissue factor (TF) binds the serine protease factor VIIa to activate coagulation or, alternatively, to trigger signaling through the G protein-coupled, protease-activated receptor 2 (PAR2) relevant to inflammation and angiogenesis. Here we demonstrate that TF(.)VIIa-mediated coagulation and cell signaling involve distinct cellular pools of TF. The surf ace-accessible, extracellular Cys(186)-Cys(209) disulfide bond of TF is critical for coagulation, and protein disulfide isomerase (PDI) disables coagulation by targeting this disulfide. A TF mutant (TF C209A) with an unpaired Cys(186) retains TF-VIIa signaling activity, and it has reduced affinity for VIIa, a characteristic of signaling TF on cells with constitutive TF expression. We further show that PDI suppresses TF coagulant activity in a nitric oxide-dependent pathway, linking the regulation of TF thrombogenicity to oxidative stress in the vasculature. Furthermore, a unique monoclonal antibody recognizes only the noncoagulant, cryptic conformation of TF. This antibody inhibits formation of the TF(.)PAR2 complex and TF-VIIa signaling, but it does not prevent coagulation activation. These experiments delineate an upstream regulatory mechanism that controls TF function, and they provide initial evidence that TF-VIIa signaling can be specifically inhibited with minimal effects on coagulation.
引用
收藏
页码:13932 / 13937
页数:6
相关论文
共 35 条
[1]   Regulation of tissue factor-induced signaling by endogenous and recombinant tissue factor pathway inhibitor [J].
Ahamed, J ;
Belting, M ;
Ruf, W .
BLOOD, 2005, 105 (06) :2384-2391
[2]   Protease-activated receptor 2-dependent phosphorylation of the tissue factor cytoplasmic domain [J].
Ahamed, J ;
Ruf, W .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (22) :23038-23044
[3]   Tissue factor encryption [J].
Bach, RR .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2006, 26 (03) :456-461
[4]   Signaling of the tissue factor coagulation pathway in angiogenesis and cancer [J].
Belting, M ;
Ahamed, J ;
Ruf, W .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2005, 25 (08) :1545-1550
[5]   Regulation of angiogenesis by tissue factor cytoplasmic domain signaling [J].
Belting, M ;
Dorrell, MI ;
Sandgren, S ;
Aguilar, E ;
Ahamed, J ;
Dorfleutner, A ;
Carmeliet, P ;
Mueller, BM ;
Friedlander, M ;
Ruf, W .
NATURE MEDICINE, 2004, 10 (05) :502-509
[6]   Tissue factor- and factor X-dependent activation of protease-activated receptor 2 by factor VIIa [J].
Camerer, E ;
Huang, W ;
Coughlin, SR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (10) :5255-5260
[7]   Cross-talk of integrin α3β1 and tissue factor in cell migration [J].
Dorfleutner, A ;
Hintermann, E ;
Tarui, T ;
Takada, Y ;
Ruf, W .
MOLECULAR BIOLOGY OF THE CELL, 2004, 15 (10) :4416-4425
[8]   The regulation and pharmacology of endothelial nitric oxide synthase [J].
Dudzinski, DM ;
Igarashi, J ;
Greif, D ;
Michel, T .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2006, 46 :235-276
[9]   Protein disulfide isomerase and sulfhydryl-dependent pathways in platelet activation [J].
Essex, DW ;
Li, MR ;
Miller, A ;
Feinman, RD .
BIOCHEMISTRY, 2001, 40 (20) :6070-6075
[10]   Tissue factor-factor VIIa-specific up-regulation of IL-8 expression in MDA-MB-231 cells is mediated by PAR-2 and results in increased cell migration [J].
Hjortoe, GM ;
Petersen, LC ;
Albrektsen, T ;
Sorensen, BB ;
Norby, PL ;
Mandal, SK ;
Pendurthi, UR ;
Rao, LVM .
BLOOD, 2004, 103 (08) :3029-3037